MASH Pathogenesis and Therapeutic Approaches

This meeting will cover the latest on the genetic etiology of metabolic dysfunction-associated steatohepatitis (MASH), metabolic and inflammatory drivers of the disease, preclinical modeling of the disease, non-invasive markers for diagnosis, and existing and emerging therapeutics. The meeting will be held jointly with the Keystone Symposium on Obesity and Adipose Tissue to encourage cross-disciplinary insights and collaborations toward understanding underlying mechanisms of how obesity leads